CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
157 hedge funds and large institutions have $1.39B invested in Clovis Oncology, Inc. in 2015 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 57 increasing their positions, 51 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
54% less funds holding in top 10
Funds holding in top 10: 13 → 6 (-7)
57% less capital invested
Capital invested by funds: $3.27B → $1.39B (-$1.87B)
Holders
157
Holding in Top 10
6
Calls
$47.8M
Puts
$28.8M
Top Buyers
| 1 | +$121M | |
| 2 | +$62.4M | |
| 3 | +$53.4M | |
| 4 |
Millennium Management
New York
|
+$30.7M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$29.3M |
Top Sellers
| 1 | -$76.9M | |
| 2 | -$38.5M | |
| 3 | -$29.2M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$24.8M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$21.7M |